体外受精女性超声子宫内膜厚度小于7毫米增加胎盘植入谱系风险
本研究纳入2008年1月至2020年12月在广州医科大学附属第三医院经体外受精或卵胞浆内单精子注射-胚胎移植后分娩且无剖宫产史的4637例女性,分析移植前子宫内膜厚度与胎盘植入谱系的关系。结果显示子宫内膜厚度小于7毫米是胎盘植入谱系的独立危险因素,且子宫内膜厚度在孕次和卵巢刺激方案与胎盘植入谱系的关联中起显著中介作用。
要点
- 无剖宫产史行辅助生殖技术治疗的女性中,子宫内膜厚度小于7毫米是胎盘植入谱系的独立危险因素。
- 子宫内膜厚度对胎盘植入谱系的影响在厚度达10.9毫米前显著,超过后效应趋于平缓。
- 子宫内膜厚度中介了孕次和卵巢刺激方案对胎盘植入谱系总效应的约63.9%和18.6%。
核心结论
- 子宫内膜薄是无剖宫产史行辅助生殖技术治疗女性发生胎盘植入谱系的独立危险因素,其临床意义略低于前置胎盘。
- 子宫内膜厚度在孕次或卵巢刺激方案与胎盘植入谱系的关联中起显著中介作用。
研究设计与样本
- 本研究为队列研究,纳入2008年1月至2020年12月在广州医科大学附属第三医院经体外受精或卵胞浆内单精子注射-胚胎移植后分娩且无剖宫产史的4637例女性。
- 采用光滑曲线拟合、阈值效应和饱和效应分析探讨子宫内膜厚度与胎盘植入谱系的关系,并行多因素logistic回归分析、倾向性评分匹配和因果中介效应分析。
主要发现
- 4637例女性中,胎盘植入谱系组159例(3.4%),其移植前末次超声子宫内膜厚度为8.88±2.21毫米,非胎盘植入谱系组为10.08±2.04毫米(P<.001)。
- 子宫内膜厚度≤7、>7至≤10.9、>10.9至≤13和>13毫米组的胎盘植入谱系绝对发生率分别为11.91%、3.73%、1.35%和2.54%。
- 与子宫内膜厚度10.9至13毫米组相比,7至10.9毫米组的调整比值比为2.27(95%置信区间1.33-3.86),小于7毫米组的调整比值比为7.15(95%置信区间3.73-13.71)。
- 前置胎盘仍是胎盘植入谱系的独立危险因素(调整比值比11.80,95%置信区间7.65-18.19)。
- 倾向性评分匹配后,子宫内膜厚度小于7毫米仍是胎盘植入谱系的独立危险因素(调整比值比3.91,95%置信区间1.57-9.73)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prevalence of placenta accreta spectrum, a potentially life-threatening condition, has exhibited a significant global rise in recent decades. Effective screening methods and early identification strategies for placenta accreta spectrum could enable early treatment and improved outcomes. Endometrial thickness plays a crucial role in successful embryo implantation and favorable pregnancy outcomes. Extensive research has been conducted on the impact of endometrial thickness on assisted reproductive technology cycles, specifically in terms of pregnancy rates, live birth rates, and pregnancy loss rates. However, limited knowledge exists regarding the influence of endometrial thickness on placenta accreta spectrum. OBJECTIVE: This study aimed to evaluate the association between preimplantation endometrial thickness and the occurrence of placenta accreta spectrum in women undergoing assisted reproductive technology cycles. STUDY DESIGN: A total of 4637 women who had not undergone previous cesarean delivery and who conceived by in vitro fertilization or intracytoplasmic sperm injection-embryo transfer treatment and subsequently delivered at the Third Affiliated Hospital of Guangzhou Medical University between January 2008 and December 2020 were included in this study. To explore the relationship between endometrial thickness and placenta accreta spectrum, we used smooth curve fitting, threshold effect, and saturation effect analysis. Multivariate logistic regression analysis was performed to evaluate the independent association between endometrial thickness and placenta accreta spectrum while adjusting for potential confounding factors. Propensity score matching was performed to reduce the influence of bias and unmeasured confounders. Furthermore, we used causal mediation effect analysis to investigate the mediating role of endometrial thickness in the relationship between gravidity and ovarian stimulation protocol and the occurrence of placenta accreta spectrum. RESULTS: Among the 4637 women included in this study, pregnancies with placenta accreta spectrum (159; 3.4%) had significantly thinner endometrial thickness (non-placenta accreta spectrum, 10.08±2.04 mm vs placenta accreta spectrum, 8.88±2.21 mm; P<.001) during the last ultrasound before embryo transfer. By using smooth curve fitting, it was found that changes in endometrial thickness had a significant effect on the incidence of placenta accreta spectrum up to a thickness of 10.9 mm, beyond which the effect plateaued. Then, the endometrial thickness was divided into the following 4 groups: ≤7, >7 to ≤10.9, >10.9 to ≤13, and >13 mm. The absolute rates of placenta accreta spectrum in each group were 11.91%, 3.73%, 1.35%, and 2.54%, respectively. Compared with women with an endometrial thickness from 10.9 to 13 mm, the odds of placenta accreta spectrum increased from an adjusted odds ratio of 2.27 (95% confidence interval, 1.33-3.86) for endometrial thickness from 7 to 10.9 mm to an adjusted odds ratio of 7.15 (95% confidence interval, 3.73-13.71) for endometrial thickness <7 mm after adjusting for potential confounding factors. Placenta previa remained as an independent risk factor for placenta accreta spectrum (adjusted odds ratio, 11.80; 95% confidence interval, 7.65-18.19). Moreover, endometrial thickness <7 mm was still an independent risk factor for placenta accreta spectrum (adjusted odds ratio, 3.91; 95% confidence interval, 1.57-9.73) in the matched cohort after PSM. Causal mediation analysis revealed that approximately 63.9% of the total effect of gravidity and 18.6% of the total effect of ovarian stimulation protocol on placenta accreta spectrum were mediated by endometrial thickness. CONCLUSION: The findings of our study indicate that thin endometrial thickness is an independent risk factor for placenta accreta spectrum in women without previous cesarean delivery undergoing assisted reproductive technology treatment. The clinical significance of this risk factor is slightly lower than that of placenta previa. Furthermore, our results demonstrate that endometrial thickness plays a significant mediating role in the relationship between gravidity or ovarian stimulation protocol and placenta accreta spectrum.
引用
- Lai S, Zhang L, Luo Y, et al. A sonographic endometrial thickness <7 mm in women undergoing in vitro fertilization increases the risk of placenta accreta spectrum. Am J Obstet Gynecol. 2024. PMID: 38432419. doi:10.1016/j.ajog.2024.02.301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。